Ticker Details
Co-Diagnostics, Inc. Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
IPO Date:	July 12, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$7.57M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 5.37%
Avg Daily Range (30 D):	$0.11 | 5.89%
Avg Daily Range (90 D):	$0.36 | 9.67%

Institutional Daily Volume
Avg Daily Volume:	1.93M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	4M

Trade Size
Avg Trade Size (Sh.):	289
Avg Trade Size (Sh.) (30 D):	218
Avg Trade Size (Sh.) (90 D):	165

Institutional Trades
Total Institutional Trades:	368
Avg Institutional Trade:	$1.3M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$.67M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.97M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.67K

News

May 28, 2026 @ 4:07 PM Is Co-Diagnostics National Security’s Next ... Source: Jeffrey Neal Johnson

Mar 31, 2026 @ 8:01 PM Co-Diagnostics Reports Full Year 2025 Financial Re... Source: Prnewswire

Mar 25, 2026 @ 12:00 PM Co-Diagnostics Ships Diagnostic Materials to India... Source: Prnewswire

Dec 30, 2025 @ 2:00 PM Co-Diagnostics Announces Reverse Stock Split Source: Prnewswire

Dec 8, 2025 @ 5:36 PM Co-Diagnostics JV, CoSara, to Participate at VIROC... Source: Prnewswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-40.31	$-1.46	$-4.06
Diluted EPS	$-40.31	$-1.46	$-4.06
Revenue	$.72M	$.17M	$.15M
Gross Profit	$.31M	$.12M	$-.05M
Net Income / Loss	$-47.06M	$-6.28M	$-9.14M
Operating Income / Loss	$-48.96M	$-6.2M	$-9.21M
Cost of Revenue	$.41M	$.05M	$.19M
Net Cash Flow	$-7.47M	$-4.58M	$-3.65M
PE Ratio

Splits
Jan 02, 2026	1:30